About the Institute

Research Institute Fact Sheet

The California Stem Cell Research and Cures Initiative, proposed for the November 2004 statewide ballot, will create the California Institute for Regenerative Medicine ("Institute"). With participation from leading doctors, scientists, patient rights advocates, medical ethicists and research universities, the Institute will direct and oversee the nation’s most innovative and ambitious stem cell research program. The $295 million in annual funding, spread over ten years, will catapult California to the forefront of life-saving stem cell research, providing the scientific community the opportunity and critically needed resources to discover new treatments and cures for our generation and generations to come.


Establishes California Institute to fund & oversee all research...

  • Institute will be funded by $3 billion in general obligation bonds, which will be distributed in annual increments for up to ten years.
  • Grants and loans for research and facilities will be made to academic and non-profit research institutions, teaching hospitals, and commercial entities that have demonstrated success in therapy deployment.
  • Administrative costs will be capped at 3% of annual funding to ensure funds focus on research and results.

Requires all institute funds to be expended in California..

  • All grants and facilities funded by the Institute must be located in the State of California.

Establishes independent, expert and transparent leadership structure...

  • Institute oversight will be directed by leaders of California’s research and patient advocacy communities with input of eminent scientists, statewide elected officials, medical ethicists and business leaders.
  • An Independent Citizen’s Oversight Committee will administer the Institute: o Chancellors of the five UC campuses with medical schools. o Presidents or Chancellors of eight non-profit research institutions, nominated by the Governor, Lt. Governor, Treasurer and Controller. o Four California for-profit life-science entities not engaged in stem cell research. o Ten representatives of California disease advocacy groups.

Implements strict oversight to ensure ethical, financial safegaurds...

  • Strict ethics codes will be adopted and enforced through the Institute, including utilizing guidelines developed by the National Institutes of Health.
  • Mirroring existing state law, the initiative strictly prohibits human reproductive cloning.
  • The Institute will release annual reports for public review.
  • An annual independent financial audit from a certified public accounting firm will be conducted to ensure bond funds are properly spent.
  • Public disclosure of activities, grants, research and future program directions will be required.
Paid for by YES on 71: Coalition for Stem Cell Research and Cures, #1260661
Privacy Policy  |   Site Map  |   Contact Us  |   Search